EUVIMEDEUVIMED entdecken
Crossref

Next-generation PFAS 6:2 fluorotelomer sulfonate reduces plaque formation in exposed white-footed mice

Meredith E Bohannon iD, Allison M Narizzano iD, Blas A Guigni, Andrew G East, Michael J Quinn

Toxicological Sciences · 2023

DOI: 10.1093/toxsci/kfad006 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Toxicological Sciences, 2023. Verfasst von Meredith E Bohannon und 4 weiteren Autor:innen. Beteiligte Einrichtung: Toxicology Directorate, U.S. Army Public Health Center, Aberdeen Proving Ground, Maryland 21010, USA. Hauptthemen laut MEDLINE: Fluorocarbons, Alkanesulfonic Acids. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 48 Literaturangaben. Gefördert von: Strategic Environmental Research and Development Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

6:2 fluorotelomer sulfonate (6:2 FTS) has been used as a replacement for legacy per- and polyfluoroalkyl substances (PFAS). We assessed reproductive and developmental effects in a human-wildlife hybrid animal model based on the association of adverse effects linked to legacy PFAS with these sensitive life stages. In this study, white-footed mice were exposed orally to 0, 0.2, 1, 5, or 25 mg/kg-day 6:2 FTS for 112 days (4 weeks premating exposure plus at least 4 weeks mating exposure). Pregnancy and fertility indices were calculated, and litter production, total litter size, live litter size, stillbirths, litter loss, average pup weight, and pinna unfolding were assessed. Sex steroid and thyroid hormone serum levels were assessed. Body weight, histopathology, and immune function were also assessed in this study. Reproductive endpoints were not significantly altered in response to 6:2 FTS. Spleen weight increased in male mice dosed with 6:2 FTS. Immune function determined via a plaque-forming cell (PFC) assay was decreased in both male and female mice in the 2 highest doses. A low benchmark dose was calculated based on PFCs as the critical effect and was found to be 2.63 and 2.26 mg/kg-day 6:2 FTS in male and female mice, respectively. This study characterizes 6:2 FTS as being potentially immunotoxic with little evidence of effect on reproduction and development; furthermore, it models acceptable levels of exposure. These 2 pieces of information together will aid regulators in setting environmental exposure limits for this PFAS currently thought to be less toxic than other PFAS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FluorocarbonsAlkanesulfonic AcidsPregnancyHumansMaleFemaleMiceAnimalsPeromyscusReproductionFertility

Stichwörter der Autor:innen

6:2 fluorotelomer sulfonatePFASbenchmark dosedecreased immune responseplaque forming cellsreplacement

Substanzen

fluorotelomer sulfonic acidsFluorocarbonsAlkanesulfonic Acids

Autor:innen und Institutionen

  • Toxicology Directorate, U.S. Army Public Health Center, Aberdeen Proving Ground, Maryland 21010, USA.

ORCID-Profile: Meredith E Bohannon, Allison M Narizzano

Förderung

  • Strategic Environmental Research and Development Program

Zitieren

APA

Bohannon, M. E., Narizzano, A. M., Guigni, B. A., East, A. G., & Quinn, M. J. (2023). Next-generation PFAS 6:2 fluorotelomer sulfonate reduces plaque formation in exposed white-footed mice. Toxicological Sciences. https://doi.org/10.1093/toxsci/kfad006

Vancouver

Bohannon ME, Narizzano AM, Guigni BA, East AG, Quinn MJ. Next-generation PFAS 6:2 fluorotelomer sulfonate reduces plaque formation in exposed white-footed mice. Toxicological Sciences. 2023. doi:10.1093/toxsci/kfad006

BibTeX
@article{Bohannon2023,
  author = {Bohannon, Meredith E and Narizzano, Allison M and Guigni, Blas A and East, Andrew G and Quinn, Michael J},
  title = {Next-generation PFAS 6:2 fluorotelomer sulfonate reduces plaque formation in exposed white-footed mice},
  journal = {Toxicological Sciences},
  year = {2023},
  doi = {10.1093/toxsci/kfad006}
}
Kostenlos starten →